Introduction
Childhood cancer survival rates are currently high and continuously improving (Mariotto et al., 2009; Smith et al., 2014) , making infertility due to gonadotoxic therapy in cancer survivors increasingly clinically relevant. Male childhood cancer survivors are less likely to sire a pregnancy compared to their siblings (hazard ratio 0.56) (Green et al., 2010) .
Although cryopreservation of sperm is used to preserve fertility in adult men diagnosed with cancer, this option is not available for prepubertal boys as spermatogenesis does not commence until puberty. Cryopreservation of testicular tissue harbouring spermatogonial stem cells (SSCs) has recently been applied as a means to preserve fertility in pre-pubertal boys with cancer (Picton et al., 2015; Long et al., 2016) .
Although not yet available clinically in humans, autotransplantation of cultured SCCs from this testicular biopsy would allow for restoration of fertility in childhood cancer survivors (Struijk et al., 2013) . To obtain testicular tissue for cryopreservation, a biopsy has to be taken surgically before administration of any gonadotoxic agents. Although the procedure is minimally invasive, testicular damage due to inflammatory effects and vascular damage could occur. One case of scrotal dermatitis was reported in a cohort of 48 biopsies (Ginsberg et al., 2014) , whilst another reported no complications in 52 boys (Wyns et al., 2011) . Whether taking a biopsy negatively influences development or growth of the testis on the long-term in these patients is not known.
There is some data available on testicular ultrasound after testicular biopsy in a population of patients who underwent orchidopexy and also testicular biopsy. After an average 11 years, no testicular abnormalities related to testis biopsy and no testicular atrophy were noted on ultrasound (Patel et al., 2005) . Even though these results are reassuring, they may not be relevant to taking a biopsy for fertility preservation in patients with childhood cancer as the biopsy is done using a different technique and impaired wound healing and decreased cell proliferation due to sustained chemotherapy directly after biopsy may play a role in these patients (Warren Peled et al., 2010) .
To investigate the effect of a testicular biopsy specifically in this vulnerable population, we performed testicular ultrasound up to 1 year after biopsy for volume measurements to assess testicular growth and to detect haematomas or scarring.
Materials and Methods
We performed a single-center prospective cohort study between March 2011 and February 2017.
Ethical approval
National and Institutional review board approval was obtained and all parents and all patients >12 years old were required to sign a written informed consent.
Patients
Boys with cancer under the age of 18 in need of gonadotoxic therapy without the ability to ejaculate were eligible for inclusion. Exclusion criteria were intratesticular tumours or possibility of testicular seeding in case of haematological malignancies and a history of cryptorchidism or testicular torsion. Treatment in relation to the cancer diagnosis always took precedence over fertility preservation and care was taken not to cause a delay due to the biopsy procedure.
Biopsy technique
Based on scrotal ultrasound made prior to surgery, we chose the site of biopsy. The biopsy was always taken unilaterally and usually the larger testicle was chosen in order to make the surgery simpler and minimize damage to the testicular parenchyma. The procedure was performed under general anaesthesia, during the same anaesthetic window as central line placement for administration of chemotherapy, thus minimizing additional anaesthesia-related risk to the patient and lengthening the procedure for a maximum of 30-40 min.
The biopsy was performed using a microsurgical technique to minimize damage to the testis as possible. The procedure started with transverse incision of the scrotal skin, then opening of the tunica vaginalis to luxate the testis out of the scrotum. The partial opening of the tunica albuginea to carefully extract the testicular tissue for cryopreservation was done microscopically. The biopsy was taken with the aim of restricting the dissected tissue to as few lobules of seminiferous tubules as possible whilst preserving the rete testis. Biopsy size was never over 1 ml and never exceeded 50% of testicular volume. The mean resected volume was 0.32 ml. Meticulous bipolar coagulation of any bleeding vessel was done to ensure haemostasis. The tunica albuginea was closed using polyglactin 910 absorbable suture 8/0. Thereafter the tunica vaginalis and scrotal skin were closed with polyglactin 910 rapid 5/0.
Testicular tissue analysis
The side and volume of the biopsied testis as well as the biopsy volume were recorded by a technician who collected the tissue in theatre. Testicular tissue was cut into small pieces and preserved for later clinical use in 5% dimethyl sulfoxide (Cryosure-DMSO; WAK Chemie Medical GmbH, Steinbach/Ts., Germany) and 5% albumin (Albuman) (Sanquin, Amsterdam, The Netherlands) in human tubal fluid (HTF)-HEPES (Gynotec bv., Malden, The Netherlands). A slow freezing protocol was used, followed by vapour phase nitrogen storage (Keros et al., 2007) . A small piece of tissue was fixed in diluted Bouin's and paraffin imbedded for histological examination. The samples were classified according to the presence of the most advanced germ cell type, i.e. no germ cells present, spermatogonia only, development up to the spermatocyte stage or up to the spermatid stage.
Acute adverse effects
After biopsy, patients received standard post-operative care. Postoperative bleeding and infection were recorded up to 30 days after biopsy. Bleeding was defined as continuous bleeding where additional measures such as compression were needed to control the blood flow. Infection was defined as tympanic temperature >38.0°C with redness or swelling of the surgical wound.
Outcomes
The primary outcome was testicular growth of the biopsied testis compared to the non-biopsied testis. Volume measurements were taken before biopsy and after 1, 6 and 12 months using ultrasound with a Linear Array Transducer 8-4 MHz (IU-22 or EPIQ 5, Philips, Best, Netherlands). Testicular volume was calculated using the widely accepted formula for an ellipsoid: Length * Width * Height * 0.52 (Sakamoto et al., 2007) . This was done by a paediatric radiologist or a radiologist in training under supervision of a paediatric radiologist.
Secondary outcomes were abnormalities in testicular parenchyma. We evaluated the biopsied and non-biopsied testis for haematomas, perfusion, microlithiasis, hydroceles, epididymal cysts and fibrotic lesions. Perfusion was assessed using colour-Doppler.
Statistical analysis
The volume measurements at 1, 6 and 12 months in the biopsied and nonbiopsied testis were examined over time. We used mixed-effect linear regression modelling with time, biopsy performed and most advanced germ cell type, as well as time by biopsy performed interaction as fixed effects. The volume data are presented as a line graph. We presented the baseline characteristics and testicular parenchyma abnormalities descriptively as number and percentages. We performed all analyses in SPSS Statistics for Windows, Version 22.0, (IBM Corp. Armonk, NY).
Results
In this prospective cohort, 120 pre-pubertal boys were initially screened for inclusion, of which 27 were not asked to participate: 18 boys already received chemotherapy or the tumour-related surgery was already performed and 9 boys met other exclusion criteria. Thus, 93 boys and their parents were offered cryopreservation of testicular tissue for fertility preservation between 2011 and 2017 (Fig. 1) . The testes of 78 boys were biopsied, a participation rate of 84% (78 out of 93). Two boys were diagnosed with para-testicular rhabdomyosarcoma which resulted in radical orchiectomy, tissue for fertility preservation was taken microscopically immediately thereafter ex vivo to minimize the chance of tumour seeding. These patients were excluded from ultrasound follow-up. Six patients deceased during the follow-up Figure 1 Flowchart of inclusion process. A visual representation of all patients screened, included and ultimately analysed in testicular growth analysis. The patients for which a 6 month or 12 month follow-up ultrasound was not available was either due to the fact that they had not reached this follow-up date yet or that they declined further follow-up. period and five either declined further examinations or did not show up for appointments and were thus lost to follow-up. About 65 boys were included in follow-up but no volume measurements were performed in 1 boy, thus he was excluded. Ultimately 64 out of 78 (82,1%) boys were included in final testicular growth analysis, with all of them having completed the ultrasound at 1 month, 58 at 6 months and 55 at 1 year.
Baseline characteristics
All baseline data are summarized in Table I . Age at biopsy varied between 5 months and 15 years. Diagnoses of the tumour type indicated mostly extra cerebral solid tumours (53.1%), in which Rhabdomyosarcoma, Ewing sarcoma and Medulloblastoma were most prevalent. Pre-operative ultrasonography showed a mean volume of 2.31 ml in the right testes and 2.18 ml in the left testes (P = 0.776) and consequently the right testis was chosen more often (62.5%) as side of biopsy. Spermatogonia were present in 63/64 (98.4%) of the testicular biopsies.
Post-operative outcomes
In 2/78 (2.6%) patients a wound infection occurred, one of which had a minor infection where no additional action had to be taken. The other boy was treated with antibiotics. The complaints resolved within a few days without visible testicular damage. No second operation or orchiectomy was necessary in either case.
Testicular growth
Volumes at each time interval are shown in Fig. 2 . After an initial decrease in testis volume in both the biopsied and non-biopsied testis during the first 6 months after surgery, an increase in mean volume was observed between 6 and 12 months after surgery in both the biopsied and non-biopsied testis. Overall, biopsy had no significant impact on testicular growth (P = 0.519). Differences between the biopsied and the non-biopsied testis were also not seen when looking at subgroups defined by the stage of testicular development (spermatogonia only, development up until the spermatocyte stage or up until the spermatid stage, Fig. 3 ). As expected, there was significant correlation between the stage of testicular development and testicular growth during follow-up after biopsy (P < 0.001). A significant correlation with age and testicular growth was also observed (P < 0.001, Fig. 4) . Secondary outcomes are summarized in Table II . A total of 7/64 (10.9%) boys had intra-scrotal haematomas at 1 month after surgery. In 5/64 (7.8%) boys these were only extra-testicular and in 2/64 (3.1%) boys the haematoma was intratesticular. Ultrasonography showed that all haematomas had subsided after 6 months. At the 12 month ultrasonography, very small fibrotic lesions most likely related to the biopsy were present in the testis of 4/55 (6.3%) boys. The remaining 51 testes had no abnormalities or any indication of a surgical intervention. Other abnormalities were evenly distributed among testis that had or had not undergone biopsy or were consistent before surgery and throughout the follow-up period.
Discussion
As expected, the volume of both the biopsied and the non-biopsied testis decreased in the first month after surgery due to the chemotherapy (Ramasamy and Schlegel, 2007) . However, there was no additional effect of the biopsy as the subsequent growth of the biopsied testis equalled that of the non-biopsied testis. In addition, the rate of wound infections was small (3%). Furthermore, the amount of lasting parenchymal abnormalities (4/55) was minimal, the clinical significance of which is also debatable.
One of the strengths of our study is that it is the largest cohort to date reporting extensively on the safety of testicular biopsy in this specific population of pre-pubertal boys with cancer. While previous studies have looked only into the immediate adverse effects of surgery, we have examined these children up to 1 year after biopsy. The microsurgical technique used here is also an advantage because it is based on the microsurgical testicular sperm extraction procedure, known to only minimally damage testicular tissue whilst maintaining a high yield of sperm retrieval (Ramasamy and Schlegel, 2007; Shah, 2011) .
Pre-biopsy mean testicular volume of both testis in our cohort was comparable to a historical cohort (Muller and Skakkebaek, 1983) , with our cohort having lower testicular volumes in the boys aged 5-9 years (1.9 ml vs. 3.0 ml) and higher volumes in the boys aged 10-13 years (5.7 ml vs. 3.1 ml). Testicular volumes 1 year after biopsy seemed to retain these numerical proportions, boys aged 5-9 had lower testicular volumes (1.25 ml vs. 3.0 ml) and ages 10-13 years were higher (4.52 ml vs. 3.1 ml).
Even though our cohort is the largest up until now, it is still a small cohort in which 15.8% of our inclusions could not be followed up. These drop-outs were due to death to primary illness, inability to reach the patient or the patient declined further follow-up. In addition, ultrasound measurements and the formula used to calculate testis volume do not predict actual volume precisely. The formula we used is known to underestimate testis volume by 21.3% while other formulas tend to overestimate actual volume and have a higher standard deviation (Sakamoto et al., 2007) . Because of the low variation with the method we used and the fact that the same method was consistently applied to all samples, the growth rate over time using this method is in our view the most accurate. It is important to note that testicular growth rate and volume does not assess testicular function in terms of spermatogenic progress. Future studies of this and other cohorts should focus on semen analyses, antisperm antibody levels and serum hormone levels to provide insights into the functionality of the testis in long-term follow-up after biopsy.
It is known that parents of pre-pubertal boys suffering from childhood cancer are eager to preserve fertility of their sons by cryopreserving testicular tissue (Ginsberg et al., 2010 (Ginsberg et al., , 2014 Sadri-Ardekani et al., 2013; van den Berg et al., 2007) . This is also reflected in the inclusion rate in our study of 84%, which is comparable to 77-84% cited in previous reports from other countries (Ginsberg et al., 2014; Wyns et al., 2011) . When looking into data from retrospective studies in the Netherlands where parents were asked if they wanted cryopreservation of testicular tissue, 62% would have consented (van den Berg et al., 2007) . Thus our study exceeded initial expectations in this group of patients in the Netherlands.
There were some differences in the way testicular biopsies were performed in our study as compared to earlier studies (Ginsberg et al., 2014; Wyns et al., 2011) . The cut-off value for total volume of the testis removed was lower in these reports, <5% versus a mean resected amount of tissue of 14% in our cohort. Whilst we used a microsurgical technique, it is unclear if this was also used in other studies.
Conclusion
This study aimed to provide information on the development of the testis after testicular biopsy for fertility preservation in pre-pubertal boys with cancer up to one year after surgery. During this follow-up period after biopsy, testicular growth was not impeded due to the biopsy. Acute adverse effects occurred in 3.9% of the boys and all were temporary. Only 6% of the patients had intratesticular fibrotic lesions attributable to surgery after 1 year. Thus it can be concluded that testicular biopsy for fertility preservation of pre-pubertal boys with cancer is a safe procedure with no consequences for the further development of the biopsied testis. critical revision of the manuscript. S.R. contributed to study conception and design, data analysis and interpretation, critical revision of the manuscript. All authors gave final approval of the version to be published. All agree to be accountable for all aspects of the work presented here.
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